121 related articles for article (PubMed ID: 7499266)
1. Identification of an I kappa B alpha-associated protein kinase in a human monocytic cell line and determination of its phosphorylation sites on I kappa B alpha.
Kuno K; Ishikawa Y; Ernst MK; Ogata M; Rice NR; Mukaida N; Matsushima K
J Biol Chem; 1995 Nov; 270(46):27914-9. PubMed ID: 7499266
[TBL] [Abstract][Full Text] [Related]
2. Lipopolysaccharide induces phosphorylation of MAD3 and activation of c-Rel and related NF-kappa B proteins in human monocytic THP-1 cells.
Cordle SR; Donald R; Read MA; Hawiger J
J Biol Chem; 1993 Jun; 268(16):11803-10. PubMed ID: 8505309
[TBL] [Abstract][Full Text] [Related]
3. Constitutive phosphorylation of I kappa B alpha by casein kinase II.
Barroga CF; Stevenson JK; Schwarz EM; Verma IM
Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7637-41. PubMed ID: 7644469
[TBL] [Abstract][Full Text] [Related]
4. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit nuclear factor-kappa B-dependent gene activation at multiple levels in the human monocytic cell line THP-1.
Delgado M; Ganea D
J Biol Chem; 2001 Jan; 276(1):369-80. PubMed ID: 11029467
[TBL] [Abstract][Full Text] [Related]
5. N- and C-terminal sequences control degradation of MAD3/I kappa B alpha in response to inducers of NF-kappa B activity.
Whiteside ST; Ernst MK; LeBail O; Laurent-Winter C; Rice N; Israël A
Mol Cell Biol; 1995 Oct; 15(10):5339-45. PubMed ID: 7565683
[TBL] [Abstract][Full Text] [Related]
6. Establishment of lipopolysaccharide-dependent nuclear factor kappa B activation in a cell-free system.
Ishikawa Y; Mukaida N; Kuno K; Rice N; Okamoto S; Matsushima K
J Biol Chem; 1995 Feb; 270(8):4158-64. PubMed ID: 7876168
[TBL] [Abstract][Full Text] [Related]
7. IKK beta and phosphatidylinositol 3-kinase/Akt participate in non-pathogenic Gram-negative enteric bacteria-induced RelA phosphorylation and NF-kappa B activation in both primary and intestinal epithelial cell lines.
Haller D; Russo MP; Sartor RB; Jobin C
J Biol Chem; 2002 Oct; 277(41):38168-78. PubMed ID: 12140289
[TBL] [Abstract][Full Text] [Related]
8. Shared pathways of IkappaB kinase-induced SCF(betaTrCP)-mediated ubiquitination and degradation for the NF-kappaB precursor p105 and IkappaBalpha.
Heissmeyer V; Krappmann D; Hatada EN; Scheidereit C
Mol Cell Biol; 2001 Feb; 21(4):1024-35. PubMed ID: 11158290
[TBL] [Abstract][Full Text] [Related]
9. All three IkappaB isoforms and most Rel family members are stably associated with the IkappaB kinase 1/2 complex.
Heilker R; Freuler F; Pulfer R; Di Padova F; Eder J
Eur J Biochem; 1999 Jan; 259(1-2):253-61. PubMed ID: 9914500
[TBL] [Abstract][Full Text] [Related]
10. An 11-amino acid sequence in the cytoplasmic domain of CD40 is sufficient for activation of c-Jun N-terminal kinase, activation of MAPKAP kinase-2, phosphorylation of I kappa B alpha, and protection of WEHI-231 cells from anti-IgM-induced growth arrest.
Sutherland CL; Krebs DL; Gold MR
J Immunol; 1999 Apr; 162(8):4720-30. PubMed ID: 10202013
[TBL] [Abstract][Full Text] [Related]
11. SCF(beta-TRCP) and phosphorylation dependent ubiquitinationof I kappa B alpha catalyzed by Ubc3 and Ubc4.
Strack P; Caligiuri M; Pelletier M; Boisclair M; Theodoras A; Beer-Romero P; Glass S; Parsons T; Copeland RA; Auger KR; Benfield P; Brizuela L; Rolfe M
Oncogene; 2000 Jul; 19(31):3529-36. PubMed ID: 10918611
[TBL] [Abstract][Full Text] [Related]
12. DNA-dependent protein kinase phosphorylation of IkappaB alpha and IkappaB beta regulates NF-kappaB DNA binding properties.
Liu L; Kwak YT; Bex F; García-Martínez LF; Li XH; Meek K; Lane WS; Gaynor RB
Mol Cell Biol; 1998 Jul; 18(7):4221-34. PubMed ID: 9632806
[TBL] [Abstract][Full Text] [Related]
13. Crucial role of the amino-terminal tyrosine residue 42 and the carboxyl-terminal PEST domain of I kappa B alpha in NF-kappa B activation by an oxidative stress.
Schoonbroodt S; Ferreira V; Best-Belpomme M; Boelaert JR; Legrand-Poels S; Korner M; Piette J
J Immunol; 2000 Apr; 164(8):4292-300. PubMed ID: 10754328
[TBL] [Abstract][Full Text] [Related]
14. The zinc finger domain of NEMO is selectively required for NF-kappa B activation by UV radiation and topoisomerase inhibitors.
Huang TT; Feinberg SL; Suryanarayanan S; Miyamoto S
Mol Cell Biol; 2002 Aug; 22(16):5813-25. PubMed ID: 12138192
[TBL] [Abstract][Full Text] [Related]
15. The signal transduction pathway of CD23 (Fc epsilon RIIb) targets I kappa B kinase.
Ten RM; McKinstry MJ; Trushin SA; Asin S; Paya CV
J Immunol; 1999 Oct; 163(7):3851-7. PubMed ID: 10490984
[TBL] [Abstract][Full Text] [Related]
16. Identification of a p65 peptide that selectively inhibits NF-kappa B activation induced by various inflammatory stimuli and its role in down-regulation of NF-kappaB-mediated gene expression and up-regulation of apoptosis.
Takada Y; Singh S; Aggarwal BB
J Biol Chem; 2004 Apr; 279(15):15096-104. PubMed ID: 14711835
[TBL] [Abstract][Full Text] [Related]
17. Cellular and viral protein interactions regulating I kappa B alpha activity during human retrovirus infection.
Hiscott J; Beauparlant P; Crepieux P; DeLuca C; Kwon H; Lin R; Petropoulos L
J Leukoc Biol; 1997 Jul; 62(1):82-92. PubMed ID: 9225998
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of IkappaBalpha in the C-terminal PEST domain by casein kinase II affects intrinsic protein stability.
Lin R; Beauparlant P; Makris C; Meloche S; Hiscott J
Mol Cell Biol; 1996 Apr; 16(4):1401-9. PubMed ID: 8657113
[TBL] [Abstract][Full Text] [Related]
19. Characterization of IkappaB kinases. IkappaB-alpha is not phosphorylated by Raf-1 or protein kinase C isozymes, but is a casein kinase II substrate.
Janosch P; Schellerer M; Seitz T; Reim P; Eulitz M; Brielmeier M; Kölch W; Sedivy JM; Mischak H
J Biol Chem; 1996 Jun; 271(23):13868-74. PubMed ID: 8662925
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-kappa B activation through inhibition of activation of I kappa B alpha kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synthesis.
Shishodia S; Koul D; Aggarwal BB
J Immunol; 2004 Aug; 173(3):2011-22. PubMed ID: 15265936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
